US begins large clinical trial to test immune modulators for COVID-19 treatment

Washington, Oct 17 (IANS) The US National Institutes of Health (NIH) has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalize...

Become a proud member of 1947.com to access this content.